This inventor holds 1 USPTO granted patent. Top assignee: Mologen Forschungs Entwicklungs Und Vertriebs Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Sven König Merediz: Innovator in Immunostimulation
Introduction
Sven König Merediz is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of nucleic acid molecules that have the potential to enhance immune responses.
Latest Patents
Sven König Merediz holds a patent for "Covalently closed nucleic acid molecules for immunostimulation." This patent describes short deoxyribonucleic acid molecules that are partially single-stranded, dumbbell-shaped, and covalently closed. These molecules contain one or more unmethylated cytosine guanosine motifs (CpG motifs) and exhibit immunomodifying effects. Such molecules can be utilized for immunostimulation applications in humans or vertebrates.
Career Highlights
Sven is associated with Mologen Forschungs Entwicklungs und Vertriebs GmbH, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in medical science, particularly in enhancing immune responses.
Collaborations
Sven has collaborated with notable colleagues, including Claas Junghans and Burghardt Wittig. Their combined expertise contributes to the innovative research environment at Mologen.
Conclusion
Sven König Merediz is a key figure in the field of immunostimulation, with a focus on developing novel nucleic acid molecules. His contributions are paving the way for advancements in immunology and potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile